Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR

This article has been corrected: In Figure 5A, the ‘α-tubulin’ panel is an accidental duplicate of the ‘Akt’ panel. In addition, the ‘GLI-1’ panel has been replaced with a parallel WB evaluating GLI-1 where HCC827 shows the presence of a low level of GLI-1, thus showing 7 lanes instead of 6. The corrected Figure 5A, obtained using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Figure 5. Western blot analysis on protein lysates and experiments on cell lines established in vitro from EGFR inhibitors-resistant HCC827 human tumor xenografts.

(A) Western blot analysis on protein lysates from representative tumors of each line of treatment of EGFR-TKIs: gefitinib, afatinib, osimertinib.

Original article: Oncotarget. 2017; 8:23020–23032. 23020-23032. https://doi.org/10.18632/oncotarget.15479